Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A cream with a specific hormone blocker increases hair growth in mice.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

TRH stimulates human hair growth and extends the hair growth phase.

Targeting the PGD2-DP2 pathway may help treat hair loss.

New treatments for alopecia areata show promise in improving hair loss outcomes.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.